SCHEMBL1913620

SCHEMBL1913620

CCCC[C@@H](NN1CCC[C@H]1CO)c1cnc(-c2ccccc2)n1CCCC

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 3/20 0.38
CD274 Q9NZQ7 3/20 0.37
PDCD1 Q15116 2/20 0.37
SPHK1 Q9NYA1 7/20 0.36
KDM4E B2RXH2 2/20 0.36
ALDH1A1 P00352 2/20 0.36
CYP3A4 P08684 2/20 0.36
HPGD P15428 2/20 0.36
MAPK1 P28482 2/20 0.36
HSD17B10 Q99714 2/20 0.36
SPHK2 Q9NRA0 5/20 0.36
PDE4B Q07343 1/20 0.34
CHRNB1 P11230 1/20 0.34
CHRNB2 P17787 1/20 0.34
CHRNB4 P30926 1/20 0.34
CHRNA3 P32297 1/20 0.34
CHRNB3 Q05901 1/20 0.34
ADORA3 P0DMS8 3/20 0.33
ADORA2A P29274 3/20 0.33
ADORA2B P29275 3/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5634810 0.89 DRD2 (0.38) TSHRKDM4EALDH1A1CYP3A4HPGD
SCHEMBL5634802 0.89 DRD2 (0.38) TSHRKDM4EALDH1A1CYP3A4HPGD
SCHEMBL5634808 0.89 DRD2 (0.38) TSHRKDM4EALDH1A1CYP3A4HPGD
SCHEMBL1912803 0.89 DRD2 (0.38) TSHRKDM4EALDH1A1CYP3A4HPGD
SCHEMBL647654 0.88 CHRNB4 (0.36) TSHRKDM4EALDH1A1CYP3A4HPGD
SCHEMBL647655 0.88 CHRNB4 (0.36) TSHRKDM4EALDH1A1CYP3A4HPGD
SCHEMBL647653 0.88 CHRNB4 (0.36) TSHRKDM4EALDH1A1CYP3A4HPGD
SCHEMBL650936 0.76 TSHR (0.41) TSHRKDM4EALDH1A1CYP3A4HPGD
SCHEMBL1912801 0.76 TSHR (0.41) TSHRKDM4EALDH1A1CYP3A4HPGD
SCHEMBL1913529 0.72 TSHR (0.39) TSHRCD274PDCD1SPHK1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8119665-B2 Aryl imidazoles and related compounds as C5a receptor modulators NOVARTIS INTERNATIONAL PHARMACEUTICAL LTD. (BM) 2012-02-21 US disclosed